Benefits of Ginger as Medicine for COVID-19: Literature Study DOI Creative Commons
Amalia Tri Utami,

Abdul Ghassan Abdullah Qarrah

Journal of Biomedical Research & Environmental Sciences, Journal Year: 2022, Volume and Issue: 3(10), P. 1208 - 1223

Published: Oct. 1, 2022

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) affects other systems, including the digestive, circulatory, urogenital, and even central nervous as its receptor Angiotensin-Converting Enzyme-2 (ACE-2) is expressed in several organs, such lungs, intestine, heart, esophagus, kidneys, bladder, testes, liver brain. Different mechanisms, particular, massive virus replication, extensive apoptosis necrosis of lung-related epithelial endothelial cells, vascular leakage, hyperinflammatory responses, overproduction proinflammatory mediators, cytokine storm, oxidative stress, downregulation ACE2 impairment renin-angiotensin system contribute to pathogenesis COVID-19. Currently, COVID-19 a global pandemic with no specific antiviral treatment. The favorable abilities ginger were indicated patients suffering from osteoarthritis, neurodegenerative disorders, rheumatoid arthritis, type diabetes, respiratory distress, diseases, primary dysmenorrhea. Ginger or compounds exhibited strong anti-inflammatory antioxidant influences numerous animal models. This review provides evidence regarding potential effects against SARS-CoV-2 infection highlights antiviral, anti-inflammatory, antioxidant, immunomodulatory impacts an attempt consider this plant alternative therapeutic agent for treatment

Language: Английский

A Global Overview of Dietary Supplements: Regulation, Market Trends, Usage during the COVID-19 Pandemic, and Health Effects DOI Open Access
Ouarda Djaoudene, Anabela Romano,

Yasmine Djedjiga Bradai

et al.

Nutrients, Journal Year: 2023, Volume and Issue: 15(15), P. 3320 - 3320

Published: July 26, 2023

Over the last 20 years, use of dietary supplements (DS) has continued to grow in many countries. Due public health crisis brought on by COVID-19 pandemic and amidst fears regarding vaccines their low supply regions world, there been a marked interest DS as alternative means protecting against treating this emerging disease, well boosting immune system minimizing risk inflammation. Despite lack evidence suggest efficacy, surge sales reported parts world. Questions have also raised about effects associated with due increased during crisis. Numerous scientific studies demonstrated beneficial properties some adverse even toxic effects. In addition, given current global issue, review is needed establish status before The aim summarize impact incidence pandemic, regulation market trends. First, we provide an overview DS, including comprehensive legislative regulatory aspects USA, China, EU, Algeria. Second, describe prevalence most commonly consumed efficacy prophylactic modality era COVID-19. Additionally, examine structure size countries that predominantly produce import them, its trend, growth. Finally, review, discuss profile users.

Language: Английский

Citations

66

Herbal medicine use for the management of COVID-19: A review article DOI Creative Commons
Chilot Abiyu Demeke,

Alem Endashaw Woldeyohanins,

Zemene Demelash Kifle

et al.

Metabolism Open, Journal Year: 2021, Volume and Issue: 12, P. 100141 - 100141

Published: Oct. 19, 2021

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause pandemic of disease 2019 (COVID-19). For many thousands years, herbal products and dietary plants have been prescribed for various diseases by traditional healers. Thus, aim this review to present main products, their source, characteristics, potential antiviral actions concerning COVID-19. Publications on related effects were searched from different databases, such as Web Science, Google Scholar, Medline, Scopus, PubMed, until August 2021, using English key terms. According studies, there are so important medicinal with activity, which can be used viral infections or supportive treatment. lack information safety profile amount dose some limitations plants. medicine interfere COVID-19 pathogenesis inhibiting SARS-CoV-2 replication entry host cells. Some plant species

Language: Английский

Citations

101

Therapeutic potential of ginger against COVID-19: Is there enough evidence? DOI Creative Commons
Abdollah Jafarzadeh, Sara Jafarzadeh, Maryam Nemati

et al.

Journal of Traditional Chinese Medical Sciences, Journal Year: 2021, Volume and Issue: 8(4), P. 267 - 279

Published: Oct. 1, 2021

In addition to the respiratory system, severe acute syndrome coronavirus 2 (SARS-CoV-2) strikes other systems, including digestive, circulatory, urogenital, and even central nervous as its receptor angiotensin-converting enzyme (ACE2) is expressed in various organs, such lungs, intestine, heart, esophagus, kidneys, bladder, testis, liver, brain. Different mechanisms, particular, massive virus replication, extensive apoptosis necrosis of lung-related epithelial endothelial cells, vascular leakage, hyper-inflammatory responses, overproduction pro-inflammatory mediators, cytokine storm, oxidative stress, downregulation ACE2, impairment renin-angiotensin system contribute COVID-19 pathogenesis. Currently, a global pandemic with no specific anti-viral treatment. The favorable capabilities ginger were indicated patients suffering from osteoarthritis, neurodegenerative disorders, rheumatoid arthritis, type diabetes, distress, liver diseases primary dysmenorrheal. Ginger or compounds exhibited strong anti-inflammatory anti-oxidative influences numerous animal models. This review provides evidence regarding potential effects against SARS-CoV-2 infection highlights antiviral, anti-inflammatory, antioxidative, immunomodulatory impacts an attempt consider this plant alternative therapeutic agent for

Language: Английский

Citations

74

Role of dietary supplements in the continuous battle against COVID‐19 DOI
Rahela Zaman, Vignesh Ravichandran, Chung Keat Tan

et al.

Phytotherapy Research, Journal Year: 2024, Volume and Issue: 38(2), P. 1071 - 1088

Published: Jan. 2, 2024

Abstract A sudden outbreak of the COVID‐19 pandemic was a big blow to world community on every level. Created by novel coronavirus, SARS‐CoV‐2, which previously unknown human immune system. The expert opinion almost immediately united fact that most effective way fighting would be building immunity artificially via mass immunization program. However, it took about year for approval first vaccine against COVID‐19. In meantime, part general population started adapting nutritious diet plans and dietary supplements boost natural as potential prophylactic strategy SARS‐CoV‐2 infection. Whether they originate from mainstream medicine, such synthetic supplements, or traditional herbal remedies in form single poly‐herbs, these may comprise various components exhibit immunomodulatory, anti‐inflammatory, antioxidant, antimicrobial characteristics. There is substantial body predictions opinions suggesting enhancing one's with containing additional nutrients bioactive compounds like vitamins, minerals, amino acids, fatty phytochemicals, probiotics can enhance system's ability develop resistance COVID‐19, although none them have any conclusive evidence nor officially recommended World Health Organization (WHO). current review critically acclaims gap between public perception‐based preference real evidence‐based study weigh actual benefit relation prevention management.

Language: Английский

Citations

7

Use of Traditional, Complementary and Integrative Medicine During the COVID-19 Pandemic: A Systematic Review and Meta-Analysis DOI Creative Commons
Tae‐Hun Kim, Jung Won Kang, Sae-Rom Jeon

et al.

Frontiers in Medicine, Journal Year: 2022, Volume and Issue: 9

Published: May 9, 2022

Traditional, Complementary and Integrative Medicine (TCIM) has been reported to use for symptom management of coronavirus disease 2019 (COVID-19). The objective this review was identify the overall usage prevalence TCIM interventions COVID-19.

Language: Английский

Citations

21

Beliefs, awareness, use, and factors associated with herbal supplements usage among patients with chronic diseases–A cross-sectional insight from Alkharj, Saudi Arabia DOI Creative Commons
Ahmed A. Albassam,

Arwa N. Alenzi,

Norah K. Alhaqbani

et al.

PLoS ONE, Journal Year: 2024, Volume and Issue: 19(1), P. e0295116 - e0295116

Published: Jan. 17, 2024

Background Herbal supplements (HSs) are used to treat a variety of diseases and ailments. Individuals with chronic at higher risk having adverse events drug interactions from the use HSs. Aim This study determined beliefs, awareness, use, factors associated HSs usage among patients in Alkharj, Saudi Arabia. Method A cross-sectional was conducted between February June 2019. Face-to-face interviews were various out-patient clinics different hospitals. Patients diagnosed included study. Data analyzed by descriptive, comparative, inferential statistics using SAS ver. 9.4. Results The participants consisted 533 patients, mean age 53.6 ±12.9 years. most prevalent diabetes mellitus (67.7%), followed hypertension (54.8%), hyperlipidemia (53.8%). Among studied participants, 336 (63%) had least one HS, whereby commonly ginger (74.7%), mint (72%), cumin (66.7%). Almost 78% users did not consult any healthcare provider about their use. varied significantly female male ( p <0.05), 61.5% comparison (38.5%). Gender (AOR 0.328; 95% CI 0.139–0.772; = 0.0107), number 1.585; 1.084–2.318; 0.0312), 2.818; 1.507–5.269; 0.0.0012) pure patients. Conclusion results this showed that high Concurrent drugs should be well-discussed providers avoid potential or especially diseases.

Language: Английский

Citations

3

The efficacy and safety of ginger (Zingiber officinale) rhizome extract in outpatients with COVID-19: A randomized double-blind placebo-control clinical trial DOI Creative Commons
Ali Ameri,

Mehdi Farashahinejad,

Parivash Davoodian

et al.

Medicine, Journal Year: 2024, Volume and Issue: 103(22), P. e38289 - e38289

Published: May 31, 2024

Background: Ginger, a potent antiviral, anti-inflammatory, and antioxidant remedy, is potential therapeutic option for COVID-19. However, there was not enough clinical evidence about ginger We evaluated the efficacy safety of on paraclinical features in outpatients with Methods: In this randomized controlled trial, confirmed COVID-19 were randomly assigned 1:1 ratio to receive (1000 mg 3 times day 7 days) or placebo. The primary outcome viral clearance after end intervention. Oxygen saturation (S P O 2 ), body temperature, respiratory rate (RR), hospital admission, incidence adverse events also assessed. Results: A total 84 patients (42 42 control groups) randomized. statistically improved group (41.6%) compared placebo (42.8%). findings indicated that S , RR had no significant difference between groups at imaging finding pulmonary infiltrate significantly reduced th intervention group. percentage <96% decreased over study Moreover, need admission drug different follow-up period. Conclusions: Ginger impact parameters patients. demonstrated safe profile infiltrate. Trial registration: trial registered as IRCT20200506047323N1.

Language: Английский

Citations

3

Deciphering the immunoboosting potential of macro and micronutrients in COVID support therapy DOI Open Access
Gaber El‐Saber Batiha, Ali I. Al‐Gareeb,

Safaa Qusti

et al.

Environmental Science and Pollution Research, Journal Year: 2022, Volume and Issue: 29(29), P. 43516 - 43531

Published: April 7, 2022

Language: Английский

Citations

13

Network pharmacology, molecular docking, and dynamics analyses to predict the antiviral activity of ginger constituents against coronavirus infection DOI Creative Commons

Asmaa Samy,

Afnan Hassan, Nesrine M. Hegazi

et al.

Scientific Reports, Journal Year: 2024, Volume and Issue: 14(1)

Published: May 27, 2024

Abstract COVID-19 is a global pandemic that caused dramatic loss of human life worldwide, leading to accelerated research for antiviral drug discovery. Herbal medicine one the most commonly used alternative prevention and treatment many conditions including respiratory system diseases. In this study, computational pipeline was employed, network pharmacology, molecular docking simulations, dynamics analyze common phytochemicals ginger rhizomes identify candidate constituents as viral inhibitors. Furthermore, experimental assays were performed volatile non-volatile compounds assess activity oil hydroalcoholic extract. Network pharmacology analysis showed target genes are involved in related cellular processes infection. Docking highlighted five pungent zingiberenol potential inhibitors main protease (M pro ), spike receptor-binding domain (RBD), angiotensin-converting enzyme 2 (ACE2). Then, (6)-gingerdiacetate selected (MD) simulations it exhibited best binding interactions free energies over three proteins. Trajectories complexes RBD ACE2 with ligand preserved similar patterns root mean square deviation (RMSD) radius gyration (Rg) values their respective native structures. Finally, validation extract confirmed existence revealed strong IC $$_{50}$$ 50 2.727 $$\upmu \hbox {g}/\hbox {ml}$$ μ g / ml . Our study provides insights into may enhance host immune response block ACE2, thereby, inhibiting SARS-CoV-2

Language: Английский

Citations

2

Potential medicinal plants involved in inhibiting 3CLpro activity: A practical alternate approach to combating COVID-19 DOI Open Access
Fan Yang, Xiaolan Jiang, Akash Tariq

et al.

Journal of Integrative Medicine, Journal Year: 2022, Volume and Issue: 20(6), P. 488 - 496

Published: Aug. 9, 2022

Language: Английский

Citations

10